Wowzers! I think we have a new winner in terms of longevity! Nd and I are
pretty close, Mike I know you’re up there but gb you seem to be in a different league.
Anyway I agree about the tech - I’m in the field. The CEO seems to be a decent human being and scrappy too. I think this play is a nice fit for his experience. He’s been in biotech and in the canna space. I’ve corresponded with others on the leadership team, including the scientific advisory board. They seemed genuinely excited but also upfront about the impossibility of moving forward without a clear path financially.
For those who care about these things, no this is not a simple minded pump message. You can look at my posting history and in addition, when I was the mod, I placed information up top so folks could familiarize themselves with the tech. It works, there are applications out there (though mostly not for the whole body) and the FDA seems like they are finally ready to look at this for a wider use.
The company has already validated the software core with a reputable consultant. The hardware validation comes next and my guess is that they will want to upgrade some of the equipment first. (I personally am looking forward to imaging using modern equipment.) With that done, assuming they pass, the only thing left is to wrap up the formal application and submit. They have good firms committed to both of these steps.
If they close this deal we will hopefully start seeing the R&D budget start going up again quickly. Connecting this to cannabis, which is still in the growth phase, is sharp. We just have to see what kind of revenue GBI has been generating. For a tantalizing clue, people can look at GBI’s IG page at the extraction products. Then look up the going wholesale prices for distillates.... it’s a bit like guessing how many jellybeans are in the jar except the jellybeans are literally liquid gold.
